$SVRA H.C. Wainwright's Andrew Fein: "highly disappointed" with the data. Lowers the probability of success to 0%, drops the fair value target to $6 (from $22) but maintains Buy rating (counting on success in other indications, although key data readouts are not expected until H1 2020)
At the revised PT - it would be a double+ from where it is bottoming out at now.